Aurora Cannabis (ACB) Competitors $4.27 +0.17 (+4.15%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends ACB vs. PSTX, PAHC, COGT, NUVB, AVBP, IMTX, REPL, QURE, PLRX, and ETNBShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Poseida Therapeutics (PSTX), Phibro Animal Health (PAHC), Cogent Biosciences (COGT), Nuvation Bio (NUVB), ArriVent BioPharma (AVBP), Immatics (IMTX), Replimune Group (REPL), uniQure (QURE), Pliant Therapeutics (PLRX), and 89bio (ETNB). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Poseida Therapeutics Phibro Animal Health Cogent Biosciences Nuvation Bio ArriVent BioPharma Immatics Replimune Group uniQure Pliant Therapeutics 89bio Aurora Cannabis (NASDAQ:ACB) and Poseida Therapeutics (NASDAQ:PSTX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, community ranking, dividends, risk, earnings, media sentiment and valuation. Which has more risk and volatility, ACB or PSTX? Aurora Cannabis has a beta of 1.86, suggesting that its stock price is 86% more volatile than the S&P 500. Comparatively, Poseida Therapeutics has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500. Do institutionals & insiders have more ownership in ACB or PSTX? 47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 46.9% of Poseida Therapeutics shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 2.9% of Poseida Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate ACB or PSTX? Poseida Therapeutics has a consensus price target of $9.50, indicating a potential upside of 0.53%. Given Poseida Therapeutics' higher possible upside, analysts plainly believe Poseida Therapeutics is more favorable than Aurora Cannabis.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33Poseida Therapeutics 0 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is ACB or PSTX more profitable? Aurora Cannabis has a net margin of -17.47% compared to Poseida Therapeutics' net margin of -40.28%. Aurora Cannabis' return on equity of -2.19% beat Poseida Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Aurora Cannabis-17.47% -2.19% -1.56% Poseida Therapeutics -40.28%-72.26%-21.53% Does the media favor ACB or PSTX? In the previous week, Aurora Cannabis had 6 more articles in the media than Poseida Therapeutics. MarketBeat recorded 8 mentions for Aurora Cannabis and 2 mentions for Poseida Therapeutics. Poseida Therapeutics' average media sentiment score of 1.11 beat Aurora Cannabis' score of -0.15 indicating that Poseida Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aurora Cannabis 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Poseida Therapeutics 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, ACB or PSTX? Aurora Cannabis has higher revenue and earnings than Poseida Therapeutics. Poseida Therapeutics is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurora Cannabis$296.99M0.79-$48.62M-$0.76-5.62Poseida Therapeutics$150.86M6.12-$123.43M-$0.63-15.00 Does the MarketBeat Community believe in ACB or PSTX? Aurora Cannabis received 343 more outperform votes than Poseida Therapeutics when rated by MarketBeat users. However, 63.49% of users gave Poseida Therapeutics an outperform vote while only 59.56% of users gave Aurora Cannabis an outperform vote. CompanyUnderperformOutperformAurora CannabisOutperform Votes38359.56% Underperform Votes26040.44% Poseida TherapeuticsOutperform Votes4063.49% Underperform Votes2336.51% SummaryAurora Cannabis beats Poseida Therapeutics on 13 of the 19 factors compared between the two stocks. Ad Banyan Hill PublishingDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001." I put all the details together for you here — but please hurry. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$234.18M$377.32M$5.06B$9.08BDividend YieldN/AN/A4.84%4.21%P/E Ratio-5.6232.56102.6717.15Price / Sales0.795.651,121.74116.80Price / Cash19.4210.6641.3037.88Price / Book0.521.884.744.78Net Income-$48.62M-$50.37M$119.11M$225.60M7 Day Performance-0.93%-3.46%-1.86%-1.21%1 Month Performance-0.91%-6.88%11.37%3.09%1 Year Performance-8.74%-6.36%30.22%16.48% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.0905 of 5 stars$4.27+4.1%N/A-8.4%$234.18M$296.99M-5.621,073Analyst RevisionNews CoveragePSTXPoseida Therapeutics3.7439 of 5 stars$9.52+0.1%$9.50-0.2%+193.5%$930.77M$64.70M-15.10260Positive NewsPAHCPhibro Animal Health4.1177 of 5 stars$22.74+0.3%$19.00-16.4%+89.6%$921.04M$1.05B52.561,940Analyst ForecastCOGTCogent Biosciences1.9517 of 5 stars$8.28+1.6%$14.83+79.1%+51.9%$914.61MN/A-3.2980NUVBNuvation Bio2.5897 of 5 stars$2.68+2.7%$6.60+146.3%+90.1%$902.01MN/A0.0060News CoverageGap DownAVBPArriVent BioPharma0.9763 of 5 stars$26.63-0.3%$36.80+38.2%N/A$897.35MN/A0.0040News CoveragePositive NewsIMTXImmatics1.4156 of 5 stars$7.30+1.2%$16.67+128.3%-25.3%$871.30M$115.50M-10.92260REPLReplimune Group4.534 of 5 stars$12.56+0.1%$17.29+37.6%+67.4%$859.36MN/A-4.11210Insider TradeQUREuniQure3.496 of 5 stars$17.52+13.8%$32.13+83.4%+172.3%$853.98M$28.59M-3.36500Analyst ForecastPLRXPliant Therapeutics3.3603 of 5 stars$13.74+3.3%$40.50+194.8%-19.0%$836.08M$1.58M0.0090ETNB89bio1.7797 of 5 stars$7.85+2.1%$30.33+286.4%-22.4%$833.09MN/A-2.6440News CoveragePositive News Related Companies and Tools Related Companies Poseida Therapeutics Competitors Phibro Animal Health Competitors Cogent Biosciences Competitors Nuvation Bio Competitors ArriVent BioPharma Competitors Immatics Competitors Replimune Group Competitors uniQure Competitors Pliant Therapeutics Competitors 89bio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ACB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
